[Form 4] UL Solutions Inc. Insider Trading Activity

Rhea-AI Filing Summary

Alex Dadakis, Executive Vice President and President, Testing, Inspection and Certification at UL Solutions Inc. (ULS), reported the accrual and receipt of dividend equivalent rights tied to restricted stock units. On 09/08/2025 the filing shows dividend equivalents were added to two restricted stock unit grant groups: 32 dividend-equivalent shares for the grant linked to March 3, 2025 (vesting in three equal annual installments) and 10 dividend-equivalent shares for the grant linked to April 1, 2025 (also vesting in three equal annual installments). Following these accruals, the reporting person beneficially owns 15,978 shares (including related RSUs) for the March grant group and 5,204 shares (including related RSUs) for the April grant group. The Form 4 was executed by an attorney-in-fact and reflects routine equity compensation mechanics.

Insights

Securities Analyst

TL;DR Routine accrual of dividend equivalents on existing restricted stock units increases reported beneficial ownership modestly.

The Form 4 discloses non-derivative acquisitions on 09/08/2025 consisting of dividend equivalent rights that convert to Class A common stock and vest alongside the underlying restricted stock units. These amounts—32 and 10 shares—are immaterial relative to typical public-company outstanding share counts but are relevant for transparency around insider holdings and potential future dilution. The filing identifies the reporting person and their executive role, and it was signed via attorney-in-fact on 09/10/2025.

Corporate Governance Expert

TL;DR Disclosure aligns with Section 16 reporting standards; transactions appear to be routine equity-compensation accruals.

The entries describe accrual of dividend-equivalent rights tied to RSUs that vest in three equal installments. The disclosure includes post-transaction beneficial ownership counts for each grant group, clarifies vesting schedules, and notes the filing was submitted by a single reporting person. There are no indications of sales, transfers, or atypical transactions that would raise governance or compliance concerns based on the provided text.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dadakis Alex

(Last) (First) (Middle)

C/O UL SOLUTIONS INC.

333 PFINGSTEN RD

(Street)

NORTHBROOK IL 60062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UL Solutions Inc. [ ULS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	09/08/2025		A		32(2)		(3)	(3)	Class A Common Stock	32	$0	15,978(4)	D
Restricted Stock Units	(1)	09/08/2025		A		10(2)		(5)	(5)	Class A Common Stock	10	$0	5,204(4)	D

Explanation of Responses:

1. Each dividend equivalent right represents a contingent right to receive one share of the Issuer's Class A Common Stock.

2. Represents accrual of dividend equivalent rights on restricted stock units held by the Reporting Person.

3. The dividend equivalent rights accrued on restricted stock units held by the Reporting Person and vest proportionately with the restricted stock units to which they relate. The restricted stock units will vest in three equal installments on the first, second and third anniversaries of March 3, 2025.

4. Includes restricted stock units and all dividend equivalent rights that have accrued on such restricted stock units to date.

5. The dividend equivalent rights accrued on restricted stock units held by the Reporting Person and vest proportionately with the restricted stock units to which they relate. The restricted stock units will vest in three equal installments on the first, second and third anniversaries of April 1, 2025.

Remarks:

Executive Vice President and President, Testing, Inspection and Certification

	/s/ Ryan Robinson, Attorney-in-Fact	09/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider is reported on this Form 4 for ULS?

The reporting person is Alex Dadakis, Executive Vice President and President, Testing, Inspection and Certification at UL Solutions Inc.

What transactions are reported on the ULS Form 4 filed 09/10/2025?

The Form 4 reports accruals of dividend equivalent rights on restricted stock units acquired on 09/08/2025 (32 and 10 dividend-equivalent shares).

How many shares does the reporting person beneficially own after the transactions?

Post-transaction beneficial ownership is reported as 15,978 shares for the March 3, 2025 grant group and 5,204 shares for the April 1, 2025 grant group (including RSUs and accrued dividend equivalents).

Do the accrued dividend equivalents have vesting conditions?

Yes, the dividend equivalent rights vest proportionately with the underlying restricted stock units, which vest in three equal installments on the first, second and third anniversaries of the respective grant dates.

Who signed the Form 4 and when?

The Form 4 was signed by /s/ Ryan Robinson, Attorney-in-Fact on 09/10/2025.